Otonomy to Present at Two Upcoming Investor Conferences

Back to Jobs

SAN DIEGO , Feb. 24, 2020 (GLOBE NEWSWIRE) — Otonomy , Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced that David A. Weber , Ph.D., president and chief executive officer, is scheduled to present at two

Apply Now